SCHEMBL4803383

SCHEMBL4803383

CC(O)N1C(=O)C(=O)c2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CES1 P23141 9/20 0.53
TTR P02766 1/20 0.53
ALDH1A1 P00352 5/20 0.48
AGTR1 P30556 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
BCHE P06276 3/20 0.47
TGM2 P21980 1/20 0.47
CES2 O00748 1/20 0.46
GAA P10253 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CASP3 P42574 1/20 0.46
ALDH3A1 P30838 2/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
ALDH2 P05091 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6143112 0.87 CES1 (0.51) CES1ALDH1A1AGTR1MEN1KMT2A
SCHEMBL4199767 0.85 CES1 (0.57) CES1TTRALDH1A1AGTR1MEN1
SCHEMBL18281472 0.85 CES1 (0.57) CES1TTRALDH1A1AGTR1MEN1
Hydrochloric Acid SCHEMBL29591677 0.83 CES1 (0.55) CES1TTRALDH1A1AGTR1MEN1
SCHEMBL28154106 0.81 CES1 (0.53) CES1TTRALDH1A1AGTR1MEN1
SCHEMBL28138060 0.81 CES1 (0.53) CES1TTRALDH1A1AGTR1MEN1
SCHEMBL281623 0.81 KMT2A (0.61) CES1TTRALDH1A1AGTR1MEN1
SCHEMBL18258640 0.81 KMT2A (0.61) CES1TTRALDH1A1AGTR1MEN1
SCHEMBL18974288 0.81 KMT2A (0.61) CES1TTRALDH1A1AGTR1MEN1
SCHEMBL20322959 0.80 CES1 (0.52) CES1TTRALDH1A1AGTR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1434552-A1 METHOD FOR DYEING KERATINOUS FIBRES Henkel Kommanditgesellschaft auf Aktien (DE) 2004-07-07 EP claimed
WO-2003030841-A1 METHOD FOR DYEING KERATINOUS FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO claimed
US-7374583-B2 Cationic azacyanine dyes and coloring agents containing said dyes THE PROCTER & GAMBLE COMPANY (US) 2008-05-20 US disclosed
US-20070220685-A1 Cationic azacyanine dyes and coloring agents containing said dyes THE PROCTER & GAMBLE COMPANY (US) 2007-09-27 US disclosed
US-6887448-B2 Method for production of high purity silicon SOLARWORLD AG (DE) 2005-05-03 US disclosed
US-20040047797-A1 Method for production of high purity silicon SOLARWORLD AKTIENGESELLSCHAFT (DE) 2004-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070220685-A1 Cationic azacyanine dyes and coloring agents containing said dyes KRT18, DNMT1, NUP205 CES1 3549/4885TTR 2630/4885ALDH1A1 1945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.